Herpes Enfeksiyonları
Özet
Referanslar
Schnipper LE, Levin M, Crumpacker CS, Gilchrest BA. Virus replication and induction of interferon in human epidermal keratinocytes following infection with herpes simplex virus. J Invest Dermatol. 1984 Jan;82(1):94-96.
Yoshida Y, Li Z, Kurokawa M, Kawana T, Imakita M, Shiraki K. Growth of herpes simplex virus in epidermal keratinocytes determines cutaneous pathogenicity in mice. J Med Virol. 2005 Mar;75(3):421-426.
Campadelli-Fiume G, Cocchi F, Menotti L, Lopez M. The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells. Rev Med Virol. 2000 Sep-Oct;10(5):305-319.
Cunningham AL, Diefenbach RJ, Miranda-Saksena M, Bosnjak L, Kim M, Jones C, Douglas MW. The cycle of human herpes simplex virus infection: virus transport and immune control. J Infect Dis. 2006 Sep 15;194 Suppl 1:S11-S18.
Heininger U, Seward JF. Varicella. Lancet. 2006 Oct 14;368(9544):1365-1376.
Hurwitz ES, Barrett MJ, Bregman D, Gunn WJ, Schonberger LB, Fairweather WR, Drage JS, LaMontagne JR, Kaslow RA, Burlington DB, et al. Public Health Service study on Reye's syndrome and medications. Report of the pilot phase. N Engl J Med. 1985 Oct 3;313(14):849-857.
Dworkin RH, Johnson RW, Breuer J, Gnann JW, Levin MJ, Backonja M, Betts RF, Gershon AA, Haanpaa ML, McKendrick MW, Nurmikko TJ, Oaklander AL, Oxman MN, Pavan-Langston D, Petersen KL, Rowbotham MC, Schmader KE, Stacey BR, Tyring SK, van Wijck AJ, Wallace MS, Wassilew SW, Whitley RJ. Recommendations for the management of herpes zoster. Clin Infect Dis. 2007 Jan 1;44 Suppl 1:S1-26.
Kost RG, Straus SE. Postherpetic neuralgia--pathogenesis, treatment, and prevention. N Engl J Med. 1996 Jul 4;335(1):32-42.
Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a
Referanslar
Schnipper LE, Levin M, Crumpacker CS, Gilchrest BA. Virus replication and induction of interferon in human epidermal keratinocytes following infection with herpes simplex virus. J Invest Dermatol. 1984 Jan;82(1):94-96.
Yoshida Y, Li Z, Kurokawa M, Kawana T, Imakita M, Shiraki K. Growth of herpes simplex virus in epidermal keratinocytes determines cutaneous pathogenicity in mice. J Med Virol. 2005 Mar;75(3):421-426.
Campadelli-Fiume G, Cocchi F, Menotti L, Lopez M. The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells. Rev Med Virol. 2000 Sep-Oct;10(5):305-319.
Cunningham AL, Diefenbach RJ, Miranda-Saksena M, Bosnjak L, Kim M, Jones C, Douglas MW. The cycle of human herpes simplex virus infection: virus transport and immune control. J Infect Dis. 2006 Sep 15;194 Suppl 1:S11-S18.
Heininger U, Seward JF. Varicella. Lancet. 2006 Oct 14;368(9544):1365-1376.
Hurwitz ES, Barrett MJ, Bregman D, Gunn WJ, Schonberger LB, Fairweather WR, Drage JS, LaMontagne JR, Kaslow RA, Burlington DB, et al. Public Health Service study on Reye's syndrome and medications. Report of the pilot phase. N Engl J Med. 1985 Oct 3;313(14):849-857.
Dworkin RH, Johnson RW, Breuer J, Gnann JW, Levin MJ, Backonja M, Betts RF, Gershon AA, Haanpaa ML, McKendrick MW, Nurmikko TJ, Oaklander AL, Oxman MN, Pavan-Langston D, Petersen KL, Rowbotham MC, Schmader KE, Stacey BR, Tyring SK, van Wijck AJ, Wallace MS, Wassilew SW, Whitley RJ. Recommendations for the management of herpes zoster. Clin Infect Dis. 2007 Jan 1;44 Suppl 1:S1-26.
Kost RG, Straus SE. Postherpetic neuralgia--pathogenesis, treatment, and prevention. N Engl J Med. 1996 Jul 4;335(1):32-42.
Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a
